Experimental study of lipid perfluorooctylbromide nanoparticles ultrasound contrast agent in enhanced computed tomography of rats

Chinese Journal of Medical Imaging Technology

Volumn 24, Issue 9, 2008, Pages 1341-1344

  Yang, Yang ^a   Wang, Zhi Gang ^a   Zheng, Yuan Yi ^a   Guo, Da Jing ^a   Zhao, Jian Nong ^a   Li, Ao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Nanoparticles; PFOB; Tomography, X ray computed

Indexed keywords

NANOPARTICLE; PERFLUOROOCTYL BROMIDE;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; ELECTRIC POTENTIAL; FLUIDIZATION; GREAT BLOOD VESSEL; LIGHT SCATTERING; LIVER; MICROSCOPY; NONHUMAN; PARTICLE SIZE; RAT; SPLEEN; WISTAR RAT;

EID: 56349092436     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Burgan AR, Long DM, Mattrey RF, et al. Results of pharmacokinetic and toxicologic studies with PFOB emulsions. Presented at the International Symposium on Artificial Blood Substitutes, Montreal, Canada, May 1987.
2. Hamilton A, Huang SL, Warnick D, et al. Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation, 2002,105 (23):2772-2778.
3. Tran TD, Caruthers SD, Hughes M, et al. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine, 2007,2(4):515-526.
4. Hughes MS, Lanza GM, Marsh JN, et al. Targeted ultrasonic contrast agents for molecular imaging and therapy: a brief review. Medicamundi, 2003,47(1):66-73.
5. Fruman SA, Harned RK 2nd, Marcus D, et al. perfluorocarbon bromide as a blood pool contrast agent for computed tomographic angiography. Acad Radiol, 1994,1(2):151-153.
6. Harned RK 2nd, Fruman SA, Swenson RB, et al. Time versus density enhancement of liver, spleen, and great vessels following rapid intravenous infusion of perflubron emulsion. Acad Radiol, 1995,2 (1):38-42.
7. Lanza GM., Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation, 1996,94(12):3334-3340.
8. Mattrey RF, Long DM, Multer F, et al. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. Radiology, 1982,145(3):755-758.
9. Marsh JN, Partlow KC, Abendschein DR, et al. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol, 2007,33(6): 950-958.
10. Partlow KC, Chen J, Brant JA, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanoparticles. FASEB, 2007,21(8):1647-1654.
11. Cyrus T, Winter PM, Caruthers SD, et al. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy. Expert Rev Cardiovasc Ther, 2005,3(4):705-715.
12. Schmieder AH, Winter PM, Caruthers SD, et al. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med, 2005,53(3):621-627.